HCA HCA Healthcare, Inc. Common Stock

NYSE · Health Care · Visualizza su SEC EDGAR ↗
$420,53
Prezzo · Ago 19, 2026
Fondamentali al Lug 28, 2026

Informazioni su HCA Healthcare, Inc. Common Stock Panoramica della società da Wikipedia

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

Leggi di più

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

HCA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$420.53
Capitalizzazione di Mercato
$94.45B
P/E (TTM)
14.8
EPS (TTM)
$28.33
Ricavi (TTM)
$75.60B
Rendimento div.
0.72%
ROE
-159.1%
D/E Debito/Patrimonio
-6.9
Intervallo 52 sett.
$354 – $557

HCA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $75.60B
10-point trend, +82.2%
2016-12-31 2025-12-31
EPS $28.33
10-point trend, +288.1%
2016-12-31 2025-12-31
Flusso di cassa libero $7.69B
10-point trend, +165.9%
2016-12-31 2025-12-31
Margini 9.0%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
HCA
Mediana dei peer
P/E (TTM)
5-point trend, +35.7%
14.8
20.3
P/S (TTM)
5-point trend, +3.8%
1.2
1.1
P/B
5-point trend, +79.3%
-15.7
4.5
EV / EBITDA
5-point trend, +5.5%
38.3
Price / FCF (Prezzo / FCF)
5-point trend, -6.5%
12.3

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
HCA
Mediana dei peer
Net Profit Margin (Margine di Profitto Netto)
5-point trend, -24.2%
9.0%
7.4%
ROA
5-point trend, -20.3%
11.3%
6.6%
ROE
5-point trend, +95.9%
-159.1%
23.2%

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
HCA
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
5-point trend, +81.4%
-6.9
Current Ratio (Rapporto corrente)
5-point trend, -31.7%
1.0
1.2
Quick Ratio
5-point trend, -26.9%
0.7

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
HCA
Mediana dei peer
Revenue YoY (Ricavi YoY)
5-point trend, +28.7%
7.1%
Revenue CAGR 3Y (CAGR Ricavi 3Y)
5-point trend, +28.7%
7.9%
Revenue CAGR 5Y (CAGR Ricavi 5Y)
5-point trend, +28.7%
8.0%
EPS YoY
5-point trend, +33.9%
28.8%
Net Income YoY (Utile Netto YoY)
5-point trend, -2.5%
17.8%

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
HCA
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
5-point trend, +33.9%
$28.33

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
HCA
Mediana dei peer
Payout Ratio (Rapporto di Distribuzione Utili)
5-point trend, +11.6%
10.0%

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

Dividend Yield
0.72%
Rapporto di Distribuzione Utili
10.0%
CAGR Dividendi 5Y
Data ex-dividendoImporto
16 Giugno 2026$0,7800
17 Marzo 2026$0,7800
15 Dicembre 2025$0,7200
16 Settembre 2025$0,7200
16 Giugno 2025$0,7200
17 Marzo 2025$0,7200
13 Dicembre 2024$0,6600
16 Settembre 2024$0,6600
14 Giugno 2024$0,6600
14 Marzo 2024$0,6600
13 Dicembre 2023$0,6000
14 Settembre 2023$0,6000
15 Giugno 2023$0,6000
16 Marzo 2023$0,6000
13 Dicembre 2022$0,5600
15 Settembre 2022$0,5600
15 Giugno 2022$0,5600
16 Marzo 2022$0,5600
13 Dicembre 2021$0,4800
15 Settembre 2021$0,4800

HCA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 30 analisti
  • Acquisto forte 6 20,0%
  • Compra 11 36,7%
  • Mantieni 12 40,0%
  • Vendi 1 3,3%
  • Vendita forte 0 0,0%

Target Price a 12 Mesi

21 analisti · 2026-08-17
Target mediano $450.00 +7,0%
Target medio $454.57 +8,1%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
0.49%
Periodo EPS Actual EPS Stimato Sorpresa
30 Giugno 2026 $7.62 $7.54 0.08%
31 Marzo 2026 $7.15 $7.21 -0.06%
31 Dicembre 2025 $8.14 $7.53 0.61%
30 Settembre 2025 $6.96 $5.77 1.2%
30 Giugno 2025 $6.83 $6.31 0.52%
31 Marzo 2025 $6.45 $5.84 0.61%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
HCA $104.86B 16.5 7.1% 9.0% -159.1%
THC $17.28B 12.8 3.1% 11.1% 56.4%
EHC $10.61B 19.2 10.5% 9.5% 25.1%
ENSG $10.12B 29.8 18.7% 6.8% 16.9%
UHS 9.4 9.7% 8.6% 21.4%
PACS $6.01B 31.5 29.3% 3.6% 23.1%
CON $2.53B 15.1 13.9% 7.7% 49.8%
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9%
SNDA $612M -7.7 25.2% -18.6% -197.2%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 12
Dati annuali Conto Economico per HCA
Metrica Tendenza 2025202420232022202120202019201820172016
Revenue 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
SG&A Expense 10-point trend, +59.8% $548M $421M $353M $307M $337M $416M $370M $344M $340M $343M
Operating Expenses 10-point trend, +79.3% $65.77B $62.08B $57.26B $51.65B $48.92B $46.10B $46.09B $41.34B $39.23B $36.68B
Interest Expense 10-point trend, +31.7% $2.25B $2.06B $1.94B $1.74B $1.57B $1.58B $1.82B $1.75B $1.69B $1.71B
Pretax Income 10-point trend, +104.4% $9.83B $8.52B $7.71B $8.58B $9.83B $5.43B $5.24B $5.33B $4.38B $4.81B
Income Tax 10-point trend, +48.8% $2.05B $1.87B $1.61B $1.75B $2.11B $1.04B $1.10B $946M $1.64B $1.38B
Net Income 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
EPS (Basic) 10-point trend, +281.1% $28.70 $22.27 $19.25 $19.43 $21.52 $11.10 $10.27 $10.90 $6.12 $7.53
EPS (Diluted) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Shares (Basic) 10-point trend, -38.4% 236,413,000 258,603,000 272,404,000 290,348,000 323,315,000 338,274,000 341,210,000 347,297,000 362,305,000 383,591,000
Shares (Diluted) 10-point trend, -39.5% 239,495,000 261,806,000 276,412,000 294,666,000 328,752,000 343,605,000 348,226,000 355,303,000 372,221,000 395,851,000
EBITDA 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Stato Patrimoniale 22
Dati annuali Stato Patrimoniale per HCA
Metrica Tendenza 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +61.0% $1.04B $1.93B $935M $908M $1.45B $1.79B $621M $502M $732M $646M
Short-term Investments 5-point trend, +136.7% · · · · · $116M $147M $47M $54M $49M
Receivables 10-point trend, +86.5% $10.87B $10.75B $9.96B $8.89B $8.10B $7.05B $7.38B $6.79B $6.50B $5.83B
Inventory 10-point trend, +9.9% $1.65B $1.74B $2.02B $2.07B $1.99B $2.02B $1.85B $1.73B $1.57B $1.50B
Other Current Assets 10-point trend, +100.2% $2.22B $1.99B $2.01B $1.78B $2.01B $1.46B $1.35B $1.19B $1.17B $1.11B
Current Assets 10-point trend, +73.7% $15.78B $16.41B $14.93B $13.64B $13.54B $12.33B $11.20B $10.21B $9.98B $9.09B
PP&E (Net) 10-point trend, +90.4% $31.14B $29.41B $27.71B $25.57B $24.06B $23.20B $22.71B $19.76B $17.89B $16.35B
PP&E (Gross) 10-point trend, +78.9% $66.28B $62.51B $58.55B $54.76B $51.35B $49.32B $47.23B $42.97B $40.08B $37.05B
Accum. Depreciation 10-point trend, +69.7% $35.13B $33.10B $30.83B $29.18B $27.29B $26.12B $24.52B $23.21B $22.19B $20.70B
Other Non-current Assets 10-point trend, -76.3% $255M $230M $184M $298M $598M $546M $480M $690M $710M $1.07B
Total Assets 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Accounts Payable 10-point trend, +101.0% $4.66B $4.28B $4.23B $4.24B $4.11B $3.54B $2.90B $2.58B $2.61B $2.32B
Current Liabilities 10-point trend, +180.3% $16.35B $15.18B $12.65B $9.90B $9.58B $8.70B $7.76B $7.57B $6.16B $5.83B
Capital Leases 7-point trend, +23.6% $1.85B $1.86B $1.90B $1.75B $1.75B $1.67B $1.50B · · ·
Total Liabilities 4-point trend, +15.8% · · · · · · $45.62B $42.12B $41.59B $39.39B
Long-term Debt 10-point trend, +41.1% $44.28B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Total Debt 10-point trend, +32.6% $41.60B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Retained Earnings 10-point trend, +17.9% $-5.72B $-2.12B $-1.35B $-2.28B $-532M $777M $-2.35B $-4.57B $-6.53B $-6.97B
AOCI 10-point trend, +9.8% $-305M $-387M $-425M $-490M $-404M $-502M $-460M $-381M $-278M $-338M
Stockholders' Equity 10-point trend, +17.5% $-6.03B $-2.50B $-1.77B $-2.77B $-933M $572M $-2.81B $-4.95B $-6.81B $-7.30B
Liabilities + Equity 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Shares Outstanding 10-point trend, -39.4% 224,605,100 249,981,400 265,537,300 277,378,300 305,476,800 339,425,600 338,445,600 342,895,200 350,091,600 370,535,900
Flusso di cassa 17
Dati annuali Flusso di cassa per HCA
Metrica Tendenza 2025202420232022202120202019201820172016
D&A 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Stock-based Comp 10-point trend, +59.8% $401M $360M $262M $341M $440M $362M $347M $268M $270M $251M
Amort. of Intangibles 6-point trend, -53.8% $12M $16M $20M $44M $25M $26M · · · ·
Other Non-cash 10-point trend, +172.2% $1.93B $1.08B $850M $-431M $-1.29B $2.40B $1.07B $461M $-3.53B $-2.67B
Operating Cash Flow 10-point trend, +123.5% $12.64B $10.51B $9.43B $8.52B $8.96B $9.23B $7.60B $6.76B $5.43B $5.65B
CapEx 10-point trend, +79.1% $4.94B $4.88B $4.74B $4.39B $3.58B $2.83B $4.16B $3.57B $3.02B $2.76B
Investing Cash Flow 10-point trend, -54.0% $-4.99B $-4.93B $-5.32B $-3.39B $-2.64B $-3.39B $-5.72B $-3.90B $-4.28B $-3.24B
Debt Issued 10-point trend, +56.9% $8.47B $7.50B $3.22B $6.00B $4.34B $2.70B $6.45B $2.00B $1.50B $5.40B
Net Debt Issued 10-point trend, +17.3% $1.08B $5.08B $2.31B $3.17B $475M $-737M $1.13B $296M $749M $925M
Stock Repurchased 10-point trend, +265.9% $10.07B $6.04B $3.81B $7.00B $8.21B $441M $1.03B $1.53B $2.05B $2.75B
Net Stock Activity 10-point trend, -265.9% $-10.07B $-6.04B $-3.81B $-7.00B $-8.21B $-441M $-1.03B $-1.53B $-2.05B $-2.75B
Dividends Paid 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·
Financing Cash Flow 10-point trend, -240.9% $-8.55B $-4.58B $-4.09B $-5.66B $-6.66B $-4.68B $-1.77B $-3.08B $-1.06B $-2.51B
Net Change in Cash 10-point trend, -840.0% $-893M $998M $27M $-543M $-342M $1.17B $119M $-230M $86M $-95M
Taxes Paid 10-point trend, +38.6% $1.74B $1.84B $1.39B $1.18B $2.18B $1.00B $849M $872M $1.21B $1.25B
Free Cash Flow 10-point trend, +165.9% $7.69B $5.64B $4.69B $4.13B $5.38B $6.40B $3.44B $3.19B $2.41B $2.89B
Levered FCF 10-point trend, +253.0% $5.91B $4.03B $3.16B $2.74B $4.15B $5.12B $2.00B $1.74B $1.35B $1.68B
Redditività 5
Dati annuali Redditività per HCA
Metrica Tendenza 2025202420232022202120202019201820172016
Net Margin 8-point trend, +10.6% 9.0% 8.2% 8.1% 9.4% 11.8% 7.3% 6.8% 8.1% · ·
Pretax Margin 8-point trend, +13.8% 13.0% 12.1% 11.9% 14.2% 16.7% 10.5% 10.2% 11.4% · ·
EBITDA Margin 8-point trend, -4.5% 4.7% 4.7% 4.7% 4.9% 4.9% 5.3% 5.1% 4.9% · ·
ROA 10-point trend, +29.8% 11.3% 10.0% 9.7% 10.9% 14.2% 8.1% 8.3% 10.0% 6.3% 8.7%
ROE 10-point trend, -310.3% -159.1% -269.6% -230.9% -305.0% -3853.7% -335.8% -90.4% -64.4% -31.4% -38.8%
Liquidità e Solvibilità 4
Dati annuali Liquidità e Solvibilità per HCA
Metrica Tendenza 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -38.0% 1.0 1.1 1.2 1.4 1.4 1.4 1.4 1.3 1.6 1.6
Quick Ratio 10-point trend, -34.8% 0.7 0.8 0.9 1.0 1.0 1.0 1.1 1.0 1.2 1.1
Debt / Equity 10-point trend, -60.6% -6.9 -17.2 -22.3 -13.8 -37.1 54.2 -12.0 -6.6 -4.9 -4.3
LT Debt / Equity 10-point trend, -61.8% -6.9 -15.3 -21.0 -13.6 -36.8 53.8 -12.0 -6.5 -4.8 -4.3
Efficienza 2
Dati annuali Efficienza per HCA
Metrica Tendenza 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +2.1% 1.3 1.2 1.2 1.2 1.2 1.1 1.2 1.2 · ·
Receivables Turnover 8-point trend, -0.4% 7.0 6.8 6.9 7.1 7.8 7.1 7.2 7.0 · ·
Per Azione 6
Dati annuali Per Azione per HCA
Metrica Tendenza 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -36.2% $-26.83 $-10.00 $-6.68 $-9.98 $-3.05 $1.69 $-8.30 $-14.44 $-19.44 $-19.71
Revenue / Share 8-point trend, +140.3% $315.66 $269.68 $235.04 $204.41 $178.71 $149.98 $147.42 $131.37 · ·
Cash Flow / Share 10-point trend, +269.5% $52.76 $40.16 $34.12 $28.92 $27.25 $26.87 $21.83 $19.03 $14.58 $14.28
Cash / Share 10-point trend, +165.6% $4.63 $7.73 $3.52 $3.27 $4.75 $5.28 $1.83 $1.46 $2.09 $1.74
Dividend / Share 8-point trend, +105.7% $3 $3 $2 $2 $2 $0 $2 $1 · ·
EPS (TTM) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Tassi di Crescita 10
Dati annuali Tassi di Crescita per HCA
Metrica Tendenza 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, -49.5% 7.1% 8.7% 7.9% 2.5% 14.0% · · · · ·
Revenue CAGR 3Y 3-point trend, -2.0% 7.9% 6.3% 8.0% · · · · · · ·
Revenue CAGR 5Y 8.0% · · · · · · · · ·
EPS YoY 5-point trend, -69.3% 28.8% 16.0% -0.94% -9.5% 93.6% · · · · ·
EPS CAGR 3Y 3-point trend, -30.9% 13.9% 1.3% 20.2% · · · · · · ·
EPS CAGR 5Y 21.0% · · · · · · · · ·
Net Income YoY 5-point trend, -79.2% 17.8% 9.9% -7.1% -18.9% 85.3% · · · · ·
Net Income CAGR 3Y 3-point trend, -46.2% 6.3% -6.1% 11.8% · · · · · · ·
Net Income CAGR 5Y 12.6% · · · · · · · · ·
Dividend CAGR 5Y 34.7% · · · · · · · · ·
Valutazione (TTM) 17
Dati annuali Valutazione (TTM) per HCA
Metrica Tendenza 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
Net Income TTM 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
Market Cap 10-point trend, +282.3% $104.86B $75.03B $71.88B $66.56B $78.48B $55.82B $50.03B $42.67B $30.75B $27.43B
Enterprise Value 10-point trend, +150.3% $145.42B $116.13B $110.53B $103.74B $111.61B $84.92B $82.98B $74.95B $63.02B $58.11B
P/E 10-point trend, +62.5% 16.5 13.6 14.3 12.5 12.1 15.0 14.7 11.7 14.8 10.1
P/S 10-point trend, +109.8% 1.4 1.1 1.1 1.1 1.3 1.1 1.0 0.9 0.7 0.7
P/B 10-point trend, -363.2% -17.4 -30.0 -40.5 -24.1 -84.1 97.6 -17.8 -8.6 -4.5 -3.8
P / Tangible Book · · · · · 97.6 · · · ·
P / Cash Flow 10-point trend, +71.0% 8.3 7.1 7.6 7.8 8.8 6.0 6.6 6.3 5.7 4.9
P / FCF 10-point trend, +43.8% 13.6 13.3 15.3 16.1 14.6 8.7 14.5 13.4 12.8 9.5
EV / EBITDA 10-point trend, +39.7% 41.3 35.1 35.9 34.9 39.1 31.2 32.0 32.9 29.6 29.6
EV / FCF 10-point trend, -5.9% 18.9 20.6 23.6 25.1 20.7 13.3 24.1 23.5 26.1 20.1
EV / Revenue 10-point trend, +37.4% 1.9 1.6 1.7 1.7 1.9 1.6 1.6 1.6 1.4 1.4
Dividend Yield 9-point trend, +0.01 0.65% 0.92% 0.92% 0.98% 0.80% 0.27% 1.1% 1.1% 0.00% ·
Earnings Yield 10-point trend, -38.4% 6.1% 7.3% 7.0% 8.0% 8.2% 6.7% 6.8% 8.6% 6.8% 9.9%
Payout Ratio 8-point trend, -22.2% 10.0% 12.0% 12.6% 11.6% 9.0% 4.1% 15.7% 12.9% · ·
Annual Payout 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $75.60B$70.60B$64.97B$60.23B$58.75B
Utile netto $6.78B$5.76B$5.24B$5.64B$6.96B
EPS Diluito $28.33$22.00$18.97$19.15$21.16
Stato Patrimoniale
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debito / Patrimonio Netto -6.9-17.2-22.3-13.8-37.1
Rapporto corrente 1.01.11.21.41.4
Quick Ratio 0.70.80.91.01.0
Flusso di cassa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flusso di cassa libero $7.69B$5.64B$4.69B$4.13B$5.38B

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 1.486 filer · $39.4B totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
128 (-51 vs trimestre precedente) 174 (+70 vs trimestre precedente) 450 (-30 vs trimestre precedente) 555 (-4 vs trimestre precedente) +16.3M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
VANGUARD GROUP INC $6.118.113.464 13.104.814 15,52% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $3.954.150.533 10.141.708 10,03% Azioni
Sanders Capital, LLC $3.442.060.818 8.828.287 8,73% Azioni
STATE STREET CORP $2.912.102.056 7.469.035 7,39% Azioni
WELLINGTON MANAGEMENT GROUP LLP $1.750.298.867 4.489.212 4,44% Azioni
GEODE CAPITAL MANAGEMENT, LLC $1.225.259.672 3.159.159 3,11% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $1.057.704.509 2.712.828 2,68% Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861.456.107 2.209.485 2,19% Azioni
NORGES BANK $836.457.140 2.145.367 2,12% Azioni
Capital World Investors $770.864.224 1.977.121 1,96% Azioni
Capital International Investors $747.403.041 1.916.947 1,90% Azioni
Crake Asset Management LLP $449.072.183 1.151.792 1,14% Azioni
Metropolis Capital Ltd $430.915.307 910.564 1,09% Azioni
Darsana Capital Partners LP $428.879.000 1.100.000 1,09% Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414.533.777 1.063.207 1,05% Azioni
Life Cycle Investment Partners Ltd $355.737.196 912.404 0,90% Azioni
VANGUARD FIDUCIARY TRUST CO $339.685.814 871.235 0,86% Azioni
FMR LLC $325.199.295 834.080 0,83% Azioni
BARCLAYS PLC $299.888.573 769.162 0,76% Azioni
LYRICAL ASSET MANAGEMENT LP $255.015.742 654.071 0,65% Azioni
BlackRock, Inc. $240.062.291 615.718 0,61% Azioni
ROYAL LONDON ASSET MANAGEMENT LTD $235.649.908 604.401 0,60% Azioni
National Pension Service $230.650.346 591.578 0,59% Azioni
NORDEA INVESTMENT MANAGEMENT AB $230.189.125 594.466 0,58% Azioni
GOLDMAN SACHS GROUP INC $209.775.669 538.038 0,53% Azioni
Gobi Capital LLC $195.742.325 502.045 0,50% Azioni
Cryder Capital Partners LLP $194.561.738 499.017 0,49% Azioni
Swiss National Bank $172.097.446 441.400 0,44% Azioni
AustralianSuper Pty Ltd $159.635.782 409.438 0,41% Azioni
Consulta Ltd $155.956.000 400.000 0,40% Azioni
LEE DANNER & BASS INC $152.150.679 390.240 0,39% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $151.472.265 388.500 0,38% Opzione Call
Mitsubishi UFJ Asset Management Co., Ltd. $147.943.761 379.450 0,38% Azioni
DIMENSIONAL FUND ADVISORS LP $139.697.405 358.300 0,35% Azioni
Vanguard Global Advisers, LLC $136.962.509 351.285 0,35% Azioni
VIRGINIA RETIREMENT SYSTEMS ET Al $134.838.505 288.820 0,34% Azioni
ALLIANCEBERNSTEIN L.P. $134.459.788 284.126 0,34% Azioni
Sumitomo Mitsui Trust Group, Inc. $132.794.974 340.596 0,34% Azioni
TD Asset Management Inc $131.847.152 338.165 0,33% Azioni
Legal & General Group Plc $127.805.162 327.798 0,32% Azioni
California Public Employees Retirement System $124.133.958 318.382 0,31% Azioni
LAZARD ASSET MANAGEMENT LLC $120.619.879 309.369 0,31% Azioni
JANE STREET GROUP, LLC $119.540.274 306.600 0,30% Opzione Call
VANGUARD ASSET MANAGEMENT, Ltd $116.069.863 297.699 0,29% Azioni
CAPTRUST FINANCIAL ADVISORS $114.741.071 294.291 0,29% Azioni
ANTIPODES PARTNERS Ltd $113.045.096 289.941 0,29% Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $109.718.328 231.845 0,28% Azioni
CITADEL ADVISORS LLC $105.660.190 271.000 0,27% Opzione Call
RHUMBLINE ADVISERS $97.580.413 250.277 0,25% Azioni
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $97.026.076 248.855 0,25% Azioni
MACKENZIE FINANCIAL CORP $93.597.383 240.061 0,24% Azioni
BloombergSen Inc. $93.160.317 238.940 0,24% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92.247.974 236.600 0,23% Opzione Put
Brandywine Global Investment Management, LLC $89.380.814 191.451 0,23% Azioni
BANK OF AMERICA CORP /DE/ $89.069.981 228.449 0,23% Azioni
NEUBERGER BERMAN GROUP LLC $85.926.216 220.386 0,22% Azioni
MILFORD FUNDS LTD $82.165.029 210.739 0,21% Azioni
Bridgewater Associates, LP $79.227.208 203.204 0,20% Azioni
Prana Capital Management, LP $75.552.494 193.779 0,19% Azioni
DANSKE BANK A/S $73.238.497 187.844 0,19% Azioni
FRANKLIN RESOURCES INC $70.965.828 182.015 0,18% Azioni
VOLORIDGE INVESTMENT MANAGEMENT, LLC $70.445.715 180.681 0,18% Azioni
Quantinno Capital Management LP $70.407.055 180.581 0,18% Azioni
ARGENT CAPITAL MANAGEMENT LLC $69.149.681 177.357 0,18% Azioni
Retirement Systems of Alabama $68.081.812 174.618 0,17% Azioni
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $66.167.842 169.709 0,17% Azioni
BNP PARIBAS FINANCIAL MARKETS $64.793.090 166.183 0,16% Azioni
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $64.665.206 165.855 0,16% Azioni
HSBC HOLDINGS PLC $64.431.534 165.332 0,16% Azioni
AVIVA PLC $64.264.789 164.828 0,16% Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $64.194.533 135.649 0,16% Azioni
SEB Asset Management AB $63.257.255 162.244 0,16% Azioni
TODD ASSET MANAGEMENT LLC $62.567.208 160.474 0,16% Azioni
Swedbank AB $62.528.998 160.376 0,16% Azioni
W1M Investment Management Ltd $61.247.490 143.647 0,16% Azioni
HARRIS ASSOCIATES L P $60.080.879 154.097 0,15% Azioni
Ensign Peak Advisors, Inc $58.372.381 149.715 0,15% Azioni
NEW YORK STATE COMMON RETIREMENT FUND $57.747.778 148.113 0,15% Azioni
CITADEL ADVISORS LLC $57.235.852 146.800 0,15% Opzione Put
Universal- Beteiligungs- und Servicegesellschaft mbH $57.160.993 146.800 0,15% Azioni
LOS ANGELES CAPITAL MANAGEMENT LLC $56.512.217 144.944 0,14% Azioni
Pictet Asset Management Holding SA $52.147.803 133.739 0,13% Azioni
VICTORY CAPITAL MANAGEMENT INC $50.752.761 130.172 0,13% Azioni
Pentwater Capital Management LP $50.685.700 130.000 0,13% Azioni
D. E. Shaw & Co., Inc. $50.554.307 129.663 0,13% Azioni
APG Asset Management N.V. $50.368.550 147.699 0,13% Azioni
AMF Tjanstepension AB $50.355.853 129.154 0,13% Azioni
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $50.349.225 129.137 0,13% Azioni
EQUITABLE TRUST CO $49.147.974 126.056 0,12% Azioni
ENVESTNET ASSET MANAGEMENT INC $48.919.124 125.469 0,12% Azioni
CANADA PENSION PLAN INVESTMENT BOARD $48.197.812 123.619 0,12% Azioni
AMERICAN CENTURY COMPANIES INC $47.460.140 121.727 0,12% Azioni
OpenArc Corporate Advisory, LLC $47.210.610 121.087 0,12% Azioni
L1 Capital International Pty Ltd $46.121.648 118.294 0,12% Azioni
FIRST TRUST ADVISORS LP $44.251.579 113.498 0,11% Azioni
PFA Pension, Forsikringsaktieselskab $44.046.098 112.971 0,11% Azioni
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund $43.830.264 112.417 0,11% Azioni
EP Wealth Advisors, LLC $43.287.826 111.026 0,11% Azioni
WOLVERINE TRADING, LLC $42.597.104 101.200 0,11% Opzione Call
MERCER GLOBAL ADVISORS INC /ADV $42.302.070 108.497 0,11% Azioni

Insider aziendali 91 insider · 54 dirigenti · 31 direttori

Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Samuel N Hazen CEO 10 Febbraio 2026 F 64.842 0 7 $-21.483.290
O'Boyle Michael P President & CEO - Parallon 26 Febbraio 2013 A 21.429 0 0 $0
Mike A Marks EVP and CFO 07 Maggio 2026 G 46.576 0 0 $0
Bill B Rutherford CFO and EVP 16 Febbraio 2024 F 22.251 0 0 $0
Russell K Harms CFO - Central Group 17 Novembre 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 Novembre 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 Novembre 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 01 Luglio 2005 F 13.865 0 0 $0
Erol R Akdamar Group President 12 Novembre 2024 M 6.843 0 0 $0
Timothy M Mcmanus Group President 31 Luglio 2024 M 27.008 0 0 $0
Richard A Hammett Group President 16 Febbraio 2024 F 17.936 0 0 $0
Charles J Hall Group President 11 Novembre 2022 M 202.443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 Novembre 2022 S 30.807 0 0 $0
Paul W Rutledge Group President 31 Dicembre 2012 A 335.657 0 0 $0
Beverly B Wallace President - Parallon 02 Novembre 2011 M 144.714 0 0 $0
Charles Robert Evans President - Eastern Group 26 Luglio 2006 A 62.173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 Ottobre 2005 A 26.154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 Ottobre 2004 D 9.029 0 0 $0
Jay Grinney President-Eastern Group 07 Maggio 2004 D 24.177 0 0 $0
Jon M Foster EVP and COO 10 Febbraio 2026 F 23.062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 13 Febbraio 2026 M 8.853 0 2 $-2.747.520
Jennifer Berres SVP & Chief Human Res. Officer 11 Febbraio 2026 S 11.993 0 2 $-4.126.932
Christopher F. Wyatt SVP & Controller 11 Febbraio 2026 S 44.379 0 1 $-2.020.000
Erica Rossitto SVP & Chief Nurse Executive 10 Febbraio 2026 F 10.407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 Febbraio 2026 F 32.080 0 1 $-747.135
Sammie S Mosier SVP & Chief Nurse Executive 13 Febbraio 2025 F 11.113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 Novembre 2024 S 9.454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 Novembre 2024 M 52.702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 05 Agosto 2024 G 18.526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 Luglio 2024 S 3.510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 Luglio 2024 S 17.755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 09 Maggio 2024 S 5.185 0 0 $0
Chad J Wasserman SVP and CIO 18 Marzo 2024 M 1.576 0 0 $0
Martin P. Paslick SVP and CIO 12 Aprile 2023 M 24.643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 09 Novembre 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 05 Maggio 2021 S 50.062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 Febbraio 2021 F 5.578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 Febbraio 2021 F 10.122 0 0 $0
Victor L Campbell SVP-Government Affairs 01 Maggio 2019 A 194.145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 Febbraio 2019 M 84.157 0 0 $0
Milton R Johnson Chairman 25 Febbraio 2019 M 881.823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 Febbraio 2018 M 7.003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 Febbraio 2018 M 35.546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 Febbraio 2018 M 65.199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 Maggio 2017 M 26.378 0 0 $0
David Gwin Anderson SVP - Finance 07 Novembre 2016 M 110.167 0 0 $0
Donald W Stinnett SVP & Controller 25 Febbraio 2016 A 51.965 0 0 $0
Noel B Williams SVP and CIO 16 Maggio 2012 M 299.030 0 0 $0
Jack O Bovender JR Chairman 06 Ottobre 2009 A 188.340 0 0 $0
Carl V George SVP - Development 27 Febbraio 2009 M 13.092 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 4 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante Depositato Partecipazione Stato Scopo Deposito
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 Febbraio 2026 31,60% Deposito iniziale SEC
22 Novembre 2006 Deposito iniziale SEC
Merrill Lynch Bank USA 11 Settembre 2006 Deposito iniziale SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 04 Agosto 2006 Deposito iniziale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 207 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
IHF · iShares Trust 4,67% 141.320 SH 08 Agosto 2026 Giornaliero
BUL · Pacer Funds Trust 3,91% 11.437 NS 30 Aprile 2026 N-PORT
YALL · Tidal Trust I 3,61% 9.261 NS 31 Maggio 2026 N-PORT
BWTG · ETF Opportunities Trust 3,02% 1.646 NS 31 Maggio 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2,32% 99.335 SH 08 Agosto 2026 Giornaliero
ABIG · EA Series Trust 2,00% 2.938 NS 29 Maggio 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1,99% 39.985 NS 30 Aprile 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,67% 31.685 SH 08 Agosto 2026 Giornaliero
COWZ · Pacer Funds Trust 1,64% 688.264 NS 30 Aprile 2026 N-PORT
QQWZ · Pacer Funds Trust 1,64% 1.762 NS 30 Aprile 2026 N-PORT
FEGE · RBB Fund Trust 1,46% 74.706 NS 31 Maggio 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1,39% 60.385 SH 08 Agosto 2026 Giornaliero
RPG · Invesco Exchange-Traded Fund Trust 1,30% 63.448 SH 08 Agosto 2026 Giornaliero
TMFE · RBB Fund, Inc. 1,29% 2.892 NS 31 Maggio 2026 N-PORT
AMID · EA Series Trust 1,23% 3.402 NS 29 Maggio 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1,15% 7.180 NS 30 Aprile 2026 N-PORT
FMAG · FIDELITY COVINGTON TRUST 1,12% 6.544 NS 30 Aprile 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1,12% 73.639 NS 30 Aprile 2026 N-PORT
SRHQ · Elevation Series Trust 1,10% 4.883 NS 30 Aprile 2026 N-PORT
IYH · iShares Trust 0,99% 89.420 SH 08 Agosto 2026 Giornaliero
NEAR · iShares U.S. ETF Trust 0,99% 48.109.000 SH 08 Agosto 2026 Giornaliero
CURE · Direxion Shares ETF Trust 0,98% 3.122 NS 30 Aprile 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,90% 470.451 SH 08 Agosto 2026 Giornaliero
NFRA · FlexShares Trust 0,88% 62.176 NS 30 Aprile 2026 N-PORT
REVS · Columbia ETF Trust I 0,87% 5.693 NS 30 Aprile 2026 N-PORT
RXL · ProShares Trust 0,86% 1.632 NS 31 Maggio 2026 N-PORT
DIVB · iShares Trust 0,85% 36.806 SH 08 Agosto 2026 Giornaliero
BSCT · Invesco Exchange-Traded Self-Indexe… 0,82% 24.078.000 08 Agosto 2026 Giornaliero
LSEQ · Harbor ETF Trust 0,81% 285 NS 30 Aprile 2026 N-PORT
IXJ · iShares Trust 0,80% 81.465 SH 08 Agosto 2026 Giornaliero
BSCS · Invesco Exchange-Traded Self-Indexe… 0,76% 26.493.000 08 Agosto 2026 Giornaliero
SPVM · Invesco Exchange-Traded Fund Trust 0,74% 2.335 SH 08 Agosto 2026 Giornaliero
FTC · First Trust Exchange-Traded AlphaDE… 0,73% 21.329 NS 30 Aprile 2026 N-PORT
RFFC · ALPS ETF Trust 0,68% 533 NS 31 Maggio 2026 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0,68% 2.698 NS 30 Aprile 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,67% 12.075 SH 08 Agosto 2026 Giornaliero
VCEB · VANGUARD WORLD FUND 0,62% 8.146.000 PA 08 Agosto 2026 Giornaliero
FDMO · FIDELITY COVINGTON TRUST 0,61% 11.771 NS 30 Aprile 2026 N-PORT
RECS · Columbia ETF Trust I 0,58% 72.768 NS 30 Aprile 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0,56% 9.664 NS 31 Maggio 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,55% 11.876 SH 08 Agosto 2026 Giornaliero
VLLU · Harbor ETF Trust 0,54% 54 NS 30 Aprile 2026 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0,53% 7.404 NS 30 Aprile 2026 N-PORT
WLDR · Two Roads Shared Trust 0,51% 844 NS 30 Aprile 2026 N-PORT
VALQ · AMERICAN CENTURY ETF TRUST 0,50% 4.620 NS 31 Maggio 2026 N-PORT
AKAF · ETF Series Solutions 0,50% 39 NS 31 Maggio 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0,50% 22.679.000 08 Agosto 2026 Giornaliero
ROUS · Lattice Strategies Trust 0,47% 6.388 NS 30 Aprile 2026 N-PORT
VCLT · VANGUARD SCOTTSDALE FUNDS 0,46% 54.218.000 PA 08 Agosto 2026 Giornaliero
CGGR · Capital Group Growth ETF 0,45% 290.273 NS 31 Maggio 2026 N-PORT